|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mangelsdorf DJ, Thummel C, Beato M,
Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M,
Chambon P, et al: The nuclear receptor superfamily: The second
decade. Cell. 83:835–839. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sudhagar S, Sathya S and Lakshmi BS: Rapid
non-genomic signalling by 17β-oestradiol through c-Src involves
mTOR-dependent expression of HIF-1α in breast cancer cells. Br J
Cancer. 105:953–960. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Béraud C, Henzel WJ and Baeuerle PA:
Involvement of regulatory and catalytic subunits of
phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad
Sci USA. 96:429–434. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang CY, Mayo MW and Baldwin AS Jr: TNF-
and cancer therapy-induced apoptosis: Potentiation by inhibition of
NF-kappaB. Science. 274:784–787. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saarinen NM, Abrahamsson A and Dabrosin C:
Estrogen-induced angiogenic factors derived from stromal and cancer
cells are differently regulated by enterolactone and genistein in
human breast cancer in vivo. Int J Cancer. 127:737–745. 2010.
View Article : Google Scholar
|
|
7
|
Heaney AP, Fernando M and Melmed S:
Functional role of estrogen in pituitary tumor pathogenesis. J Clin
Invest. 109:277–283. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
St-Germain ME, Gagnon V, Parent S and
Asselin E: Regulation of COX-2 protein expression by Akt in
endometrial cancer cells is mediated through NF-kappaB/IkappaB
pathway. Mol Cancer. 3:72004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hammes SR and Davis PJ: Overlapping
nongenomic and genomic actions of thyroid hormone and steroids.
Best Pract Res Clin Endocrinol Metab. 29:581–593. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
François CM, Wargnier R, Petit F, Goulvent
T, Rimokh R, Treilleux I, Ray-Coquard I, Zazzu V, Cohen-Tannoudji J
and Guigon CJ: 17β-estradiol inhibits spreading of metastatic cells
from granulosa cell tumors through a non-genomic mechanism
involving GPER1. Carcinogenesis. 36:564–573. 2015. View Article : Google Scholar
|
|
11
|
Zhang H, Zhao X, Liu S, Li J, Wen Z and Li
M: 17betaE2 promotes cell proliferation in endometriosis by
decreasing PTEN via NFkappaB-dependent pathway. Mol Cell
Endocrinol. 317:31–43. 2010. View Article : Google Scholar
|
|
12
|
Guzeloglu Kayisli O, Kayisli UA, Luleci G
and Arici A: In vivo and in vitro regulation of Akt activation in
human endometrial cells is estrogen dependent. Biol Reprod.
71:714–721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan TO and Tsichlis PN: PDK2: A complex
tail in one Akt. Sci STKE 2001. pe12001.
|
|
14
|
Scheid MP and Woodgett JR: PKB/AKT:
Functional insights from genetic models. Nat Rev Mol Cell Biol.
2:760–768. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Madrid LV, Wang CY, Guttridge DC,
Schottelius AJ, Baldwin AS Jr and Mayo MW: Akt suppresses apoptosis
by stimulating the transactivation potential of the RelA/p65
subunit of NF-kappaB. Mol Cell Biol. 20:1626–1638. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR,
Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis
factor requires the Akt serine-threonine kinase. Nature. 401:82–85.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Romashkova JA and Makarov SS: NF-kappaB is
a target of AKT in anti-apoptotic PDGF signalling. Nature.
401:86–90. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bryant DN, Sheldahl LC, Marriott LK,
Shapiro RA and Dorsa DM: Multiple pathways transmit neuroprotective
effects of gonadal steroids. Endocrine. 29:199–207. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Frago LM, Pañeda C, Argente J and Chowen
JA: Growth hormone-releasing peptide-6 increases insulin-like
growth factor-I mRNA levels and activates Akt in RCA-6 cells as a
model of neuropeptide Y neurones. J Neuroendocrinol. 17:701–710.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanda S, Miyata Y and Kanetake H:
Fibroblast growth factor-2-mediated capillary morphogenesis of
endothelial cells requires signals via Flt-1/vascular endothelial
growth factor receptor-1: Possible involvement of c-Akt. J Biol
Chem. 279:4007–4016. 2004. View Article : Google Scholar
|
|
21
|
Biswas DK, Shi Q, Baily S, Strickland I,
Ghosh S, Pardee AB and Iglehart JD: NF-kappa B activation in human
breast cancer specimens and its role in cell proliferation and
apoptosis. Proc Natl Acad Sci USA. 101:10137–10142. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou Y, Eppenberger-Castori S, Marx C, Yau
C, Scott GK, Eppenberger U and Benz CC: Activation of nuclear
factor-kappaB (NFkappaB) identifies a high-risk subset of
hormone-dependent breast cancers. Int J Biochem Cell Biol.
37:1130–1144. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mizumoto Y, Kyo S, Kiyono T, Takakura M,
Nakamura M, Maida Y, Mori N, Bono Y, Sakurai H and Inoue M:
Activation of NF-kappaB is a novel target of KRAS-induced
endometrial carcinogenesis. Clin Cancer Res. 17:1341–1350. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stice JP, Mbai FN, Chen L and Knowlton AA:
Rapid activation of nuclear factor κB by 17β-estradiol and
selective estrogen receptor modulators: Pathways mediating cellular
protection. Shock. 38:128–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abeyama K, Eng W, Jester JV, Vink AA,
Edelbaum D, Cockerell CJ, Bergstresser PR and Takashima A: A role
for NF-kappaB-dependent gene transactivation in sunburn. J Clin
Invest. 105:1751–1759. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shibata A, Nagaya T, Imai T, Funahashi H,
Nakao A and Seo H: Inhibition of NF-kappaB activity decreases the
VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast
Cancer Res Treat. 73:237–243. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiong HQ, Abbruzzese JL, Lin E, Wang L,
Zheng L and Xie K: NF-kappaB activity blockade impairs the
angiogenic potential of human pancreatic cancer cells. Int J
Cancer. 108:181–188. 2004. View Article : Google Scholar
|
|
28
|
Stoltz RA, Abraham NG and
Laniado-Schwartzman M: The role of NF-kappaB in the angiogenic
response of coronary microvessel endothelial cells. Proc Natl Acad
Sci USA. 93:2832–2837. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakabayashi H and Shimizu K: Involvement
of Akt/NF-κB pathway in antitumor effects of parthenolide on
glioblastoma cells in vitro and in vivo. BMC Cancer. 12:4532012.
View Article : Google Scholar
|
|
30
|
deGraffenried LA1, Chandrasekar B,
Friedrichs WE, Donzis E, Silva J, Hidalgo M, Freeman JW and Weiss
GR: NF-kappa B inhibition markedly enhances sensitivity of
resistant breast cancer tumor cells to tamoxifen. Ann Oncol.
15:885–890. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stefansson IM, Salvesen HB and Akslen LA:
Vascular proliferation is important for clinical progress of
endometrial cancer. Cancer Res. 66:3303–3309. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dai H, Zhao S, Xu L, Chen A and Dai S:
Expression of Efp, VEGF and bFGF in normal, hyperplastic and
malignant endo-metrial tissue. Oncol Rep. 23:795–799.
2010.PubMed/NCBI
|
